2F1U - Header Asymmetric Unit

HEADER SIGNALING PROTEIN RECEPTOR 15-NOV-05 2F1U

TITLE A HOMOLOGY-BASED 3D MODEL OF THE HUMAN NEUROPEPTIDE Y TITLE 2 RECEPTOR Y1

COMPND MOL_ID: 1; COMPND 2 MOLECULE: NEUROPEPTIDE Y RECEPTOR TYPE 1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: NPY1-R; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: NEUROPEPTIDE Y RECEPTOR TYPE 1; COMPND 7 CHAIN: B; COMPND 8 SYNONYM: NPY1-R; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE: NEUROPEPTIDE Y RECEPTOR TYPE 1; COMPND 11 CHAIN: C; COMPND 12 SYNONYM: NPY1-R; COMPND 13 MOL_ID: 4; COMPND 14 MOLECULE: NEUROPEPTIDE Y RECEPTOR TYPE 1; COMPND 15 CHAIN: D; COMPND 16 SYNONYM: NPY1-R; COMPND 17 MOL_ID: 5; COMPND 18 MOLECULE: NEUROPEPTIDE Y RECEPTOR TYPE 1; COMPND 19 CHAIN: E; COMPND 20 SYNONYM: NPY1-R; COMPND 21 MOL_ID: 6; COMPND 22 MOLECULE: NEUROPEPTIDE Y RECEPTOR TYPE 1; COMPND 23 CHAIN: F; COMPND 24 SYNONYM: NPY1-R; COMPND 25 MOL_ID: 7; COMPND 26 MOLECULE: NEUROPEPTIDE Y RECEPTOR TYPE 1; COMPND 27 CHAIN: G; COMPND 28 SYNONYM: NPY1-R

SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 MOL_ID: 2; SOURCE 5 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 6 ORGANISM_COMMON: HUMAN; SOURCE 7 MOL_ID: 3; SOURCE 8 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 9 ORGANISM_COMMON: HUMAN; SOURCE 10 MOL_ID: 4; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 MOL_ID: 5; SOURCE 14 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 15 ORGANISM_COMMON: HUMAN; SOURCE 16 MOL_ID: 6; SOURCE 17 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 18 ORGANISM_COMMON: HUMAN; SOURCE 19 MOL_ID: 7; SOURCE 20 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 21 ORGANISM_COMMON: HUMAN

KEYWDS TRANSMEMBRANE, ALPHA-HELIX, GPCR,

EXPDTA THEORETICAL MODEL

AUTHOR P.SJODIN,H.AKERBERG,D.LARHAMMAR

REVDAT 1 04-JUL-06 2F1U 0

JRNL AUTH P.SJODIN,S.K.S.HOLMBERG,H.AKERBERG,M.M.BERGLUND, JRNL AUTH 2 N.MOHELL,D.LARHAMMAR JRNL TITL RE-EVALUATION OF RECEPTOR-LIGAND INTERACTIONS OF JRNL TITL 2 THE HUMAN NEUROPEPTIDE Y RECEPTOR Y1: A JRNL TITL 3 SITE-DIRECTED MUTAGENESIS STUDY JRNL REF BIOCHEM.J. V. 393 161 2006 JRNL REFN ASTM BIJOAK UK ISSN 0264-6021

REMARK 1

REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE.

REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SYBYL (SUBROUTINE POWELL) REMARK 3 AUTHORS : TRIPOS (MUNICH, GERMANY) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: SEVEN RESIDUES CONSERVED AMONG THE REMARK 3 GPCR FAMILY WERE TETHERED BY CONSTRAINTS TO EACH OTHER IN THE REMARK 3 RHODOPSIN TEMPLATE. MODELLING WAS PERFORMED WITH SYBYL 6.9.1 REMARK 3 SOFTWARE RUNNING ON FEDORA CORE 2 LINUX KERNEL 2 USING THE REMARK 3 SUBROUTINE POWELL TO ENERGY-REFINE THE MODEL. THE WHOLE MODEL REMARK 3 WAS MINIMIZED WITH THE KOLLMAN UNITED FORCE FIELD. THE WHAT IF REMARK 3 V.4.99 PROGRAM AND THE RAMACHANDRAN PLOT OF THE RAMPAGE REMARK 3 PROGRAM WERE USED TO EVALUATE THE MODEL.

REMARK 4 REMARK 4 2F1U COMPLIES WITH FORMAT V. 2.3, 09-JULY-1998

REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-JAN-2006. REMARK 100 THE RCSB ID CODE IS RCSB035347.

REMARK 220 REMARK 220 EXPERIMENTAL DETAILS REMARK 220 EXPERIMENT TYPE : THEORETICAL MODELLING REMARK 220 REMARK 220 REMARK: THE HIGH-RESOLUTION (2.8 A) X-RAY CRYSTALLOGRAPHIC REMARK 220 STRUCTURE OF BOVINE RHODOPSIN WAS USED AS TEMPLATE

REMARK 225 REMARK 225 THEORETICAL MODEL REMARK 225 THE COORDINATES IN THIS ENTRY REPRESENT A MODEL STRUCTURE. REMARK 225 PROTEIN DATA BANK CONVENTIONS REQUIRE THAT CRYST1 AND REMARK 225 SCALE RECORDS BE INCLUDED, BUT THE VALUES ON THESE REMARK 225 RECORDS ARE MEANINGLESS.

DBREF 2F1U A 35 64 UNP P25929 NPY1R_HUMAN 38 67 DBREF 2F1U B 71 100 UNP P25929 NPY1R_HUMAN 74 103 DBREF 2F1U C 107 139 UNP P25929 NPY1R_HUMAN 110 142 DBREF 2F1U D 151 173 UNP P25929 NPY1R_HUMAN 153 175 DBREF 2F1U E 200 225 UNP P25929 NPY1R_HUMAN 208 233 DBREF 2F1U F 247 277 UNP P25929 NPY1R_HUMAN 258 288 DBREF 2F1U G 286 306 UNP P25929 NPY1R_HUMAN 300 320

SEQRES 1 A 30 ALA MET ILE PHE THR LEU ALA LEU ALA TYR GLY ALA VAL SEQRES 2 A 30 ILE ILE LEU GLY VAL SER GLY ASN LEU ALA LEU ILE ILE SEQRES 3 A 30 ILE ILE LEU LYS SEQRES 1 B 30 VAL THR ASN ILE LEU ILE VAL ASN LEU SER PHE SER ASP SEQRES 2 B 30 LEU LEU VAL ALA ILE MET CYS LEU PRO PHE THR PHE VAL SEQRES 3 B 30 TYR THR LEU MET SEQRES 1 C 33 GLU ALA MET CYS LYS LEU ASN PRO PHE VAL GLN CYS VAL SEQRES 2 C 33 SER ILE THR VAL SER ILE PHE SER LEU VAL LEU ILE ALA SEQRES 3 C 33 VAL GLU ARG HIS GLN LEU ILE SEQRES 1 D 23 ARG HIS ALA TYR VAL GLY ILE ALA VAL ILE TRP VAL LEU SEQRES 2 D 23 ALA VAL ALA SER SER LEU PRO PHE LEU ILE SEQRES 1 E 26 ARG LEU SER TYR THR THR LEU LEU LEU VAL LEU GLN TYR SEQRES 2 E 26 PHE GLY PRO LEU CYS PHE ILE PHE ILE CYS TYR PHE LYS SEQRES 1 F 31 THR LYS ARG ILE ASN ILE MET LEU LEU SER ILE VAL VAL SEQRES 2 F 31 ALA PHE ALA VAL CYS TRP LEU PRO LEU THR ILE PHE ASN SEQRES 3 F 31 THR VAL PHE ASP TRP SEQRES 1 G 21 LEU LEU PHE LEU LEU CYS HIS LEU THR ALA MET ILE SER SEQRES 2 G 21 THR CYS VAL ASN PRO ILE PHE TYR

HELIX 1 1 ALA A 35 LYS A 64 1 30 HELIX 2 2 VAL B 71 MET B 89 1 19 HELIX 3 3 MET B 89 MET B 100 1 12 HELIX 4 4 GLU C 107 ILE C 139 1 33 HELIX 5 5 ARG D 151 ILE D 173 1 23 HELIX 6 6 ARG E 200 TYR E 212 1 13 HELIX 7 7 TYR E 212 LYS E 225 1 14 HELIX 8 8 THR F 247 TRP F 277 1 31 HELIX 9 9 LEU G 286 MET G 296 1 11 HELIX 10 10 ILE G 297 TYR G 306 1 10

CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1

ORIGX1 1.000000 0.000000 0.000000 0.00000

ORIGX2 0.000000 1.000000 0.000000 0.00000

ORIGX3 0.000000 0.000000 1.000000 0.00000

SCALE1 1.000000 0.000000 0.000000 0.00000

SCALE2 0.000000 1.000000 0.000000 0.00000

SCALE3 0.000000 0.000000 1.000000 0.00000